References
- Saraiva M JM, Almeida M R, Sherman W, Gawinowicz M, Costa P, Costa P P, Goodman D S. A new transthyretin mutation associated with amyloid cardiomyopathy. Am J Hum. Genet 1992; 50: 1027–1030
- Nichols W C, Benson M D. Hereditary amyloidosis: detection of variant prealbumin genes by restriction enzyme analysis of amplified genomic DNA sequences. Clin Genet 1990; 37: 44–53
- Ando Y, Ohlsson P-I, Suhr O, Nyhlin N, Yamashita T, Holmgren G, Danielsson A, Sandgren O, Uchino M, Ando M. A new simple and rapid screening method of variant transthyretin (TTR) related amyloidosis. BBA 1996; 228: 480–483
- Holmgren G, Steen L, Ekstedt J, Groth C-G, Ericzon B-G, Eriksson S, Andersen O, Karlberg I, Norden G, Nakazato M, Hawkins P, Richardson S, Pepys M B. Biochemical effects of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP met-30). Clin Genet 1991; 40: 242–246
- Suhr O, Ericzon B-G, Groth C-G, Holmgren G, Steen L, Wikstrom L, Norden G. Liver-transplantation for familial amyloidotic polyneuropathy. Outcome of the first 20 Swedish transplantations. J Transplantation 1995; 60: 993
- Benson M D, Saraiva M JM, Pepys M, Ikeda S, Buxbaum J (1999) Milestones in TTR research and future aspects. Proceedings the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders & The 3rd International Workshop on Liver Transplantation in Familial Amyloidotic Polyneuropathy, Presented at the, June 3–5. June, 3–51999. Umeå, Sweden, 9
- Jacobson D R, Gertz M A, Kane I, Buxbaum J N (1993) Genetic analysis of nine unrelated patients with transthyretin (TTR) cardiac amyloidosis: correlation of clinical and genetic findings and description of 2 new transthyretin variants. Presented at the Proceedings VII International Symposium on Amyloidosis, KingstonCanada, July, 11–151993, 127
- Dubrey S W, Davidoff R, Skinner M, Bergethon P, Lewis D, Falk R H. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 1997; 64: 74–80
- Stangou A J, Hawkins P N, Heaton N D, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys M B, Williams R. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 1998; 66: 229–233
- Garcia-Herola A, Prieto M, Pascual S, Berenguer M, Lopez-Viedma B, Mir J, Vilchez J J, Berenguer J. Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant. Liver Transpl Surg 1999; 3: 246–248
- Hastrup-Svendsen I, Mortensen S A, Kirkegaard P, Suhr O B, Kazuhiro T, Olsson P-I, Ranliav P J (1999) Combined heart and liver transplantation for familial amyloid cardiomyopathy (ATTR Leu 111Met). Presented at the Proceedings the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders & The 3rd International Workshop on Liver Transplantation in Familial Amyloidotic Polyneuropathy. June, 3–51999. UmeåSweden, 76
- Connors L H, Theberge R, Skare J, Costello C E, Falk R H, Skinner M. A new transthyretin variant (Ser23 Asn) associated with familial amyloidosis in a Portuguese patient. Amyloid: Int J Exp Clin Invest 1999; 6: 114–118